A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands.
Novavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company's Covid vaccine starting next year and develop combination shots targeting the coronavirus and the flu, among other efforts.
Part of the deal allows Sanofi to use Novavax's Covid shot and flagship vaccine technology, Matrix-M adjuvant, to develop new vaccine products.
Novavax is also entitled to royalty payments on Sanofi's sales of its Covid vaccine and combination shots targeting coronavirus and the flu.
Under the deal, Sanofi will also take a less than 5% stake in Novavax.
Persons:
Novavax, Sanofi, John Jacobs, Jacobs
Organizations:
Dutch Health Service Organization, French, CNBC, Health, Pfizer, Moderna, Sanofi
Locations:
The Hague, Netherlands, Novavax